Stock screenerAll disclosures →
EDGAR →
IMMX
Conviction 80HealthcareScan · Fri, Sep 4, 2026IMMX$13.91+0.54%
ResistanceSupportVol 14Vol MA14 1.56M
Jun 8Jun 25Jul 15Jul 31Aug 19Sep 4
Price13.91
Change+0.54%
Gap-1.08%
Rel volume0.60×
Avg volume1.52M
Avg $ vol19.73M
SMA 2012.91
SMA 5011.02
SMA 2008.51
Price vs 50+26.14%
Price vs 200+63.39%
MA stackbullish
50/200 cross—
Supertrendup · 11.61
RSI (14)67
MACD hist-0.02
MACD crossbear · 0d
Stoch %K / %D70 / 72
ADX (14)39
+DI / −DI27 / 10
RSI divergence—
MACD divergence—
ATR %+5.56%
ADR %6.36%
52w high14.47
52w low1.96
From 52w high-3.90%
Above 52w low+609.44%
New 52w highNo
SqueezeOff
Bollinger width42.10%
%B0.68
Donchian pos78.03%
Donchian high15.10
Donchian low9.66
AVWAP (52w high)14.08
vs AVWAP high-1.24%
AVWAP (52w low)8.28
vs AVWAP low+67.86%
OBV trendUp
Chaikin MF (20)0.40
Today vs 20d0.60×
Avg vol (14d)1.55M
Avg vol (20d)1.52M
Avg $ vol (20d)19.73M
Market cap994.75M
RS 3m (vs SPY)+62.13%
RS 6m (vs SPY)+48.46%
RS line new highNo
Trend template8/8
Technical rank90.0
1 week-0.25%
1 month+38.22%
3 months+75.35%
6 months+49.68%
1 year+534.93%
YTD+156.08%
P/E-33.79
P/B4.35
P/S49.74
P/FCF-40.33
EPS-0.8900
Div yield—
ROE-12.86%
ROA-12.31%
Debt/Eq—
Current25.13
EV/EBITDA—
Gross margin—
Net margin-147.19%
Rev growth—
EPS growth-36.21%
Price target19.80
Target upside42.39%
Analyst ratingBuy
Institutional86.85%
Ent. value769.26M
Revenue20M
Net income-11.56M
Gross profit—
Free cash flow-24.66M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out54.41M
Employees21
ListedThu, Dec 16, 2021
Free float31.78M
Float %60.0%
Short interest10.36M
Days to cover7.0d
Short volume40.9%
Squeeze score66 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.18 vs −$0.17
Last surprise-5.9% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank90.0 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance14.68
Support7.97
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in IMMX
No recent disclosed trades by Congress in IMMX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IMMX · 7 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Adams Helen C. Director · Common Stock · 2026-05-22 | Grant | 6.25K | $0 | 2026-05-22 | 2026-05-29 |
Chudnovsky Yekaterina Director · Common Stock · 2026-05-22 | Grant | 6.25K | $0 | 2026-05-22 | 2026-05-29 |
Ng Carey Director · Common Stock · 2026-05-22 | Other | — | — | 2026-05-22 | 2026-05-29 |
Hsu Jason Director · Stock Option (Right to Buy) · 2026-05-22 | Grant | 12.5K | $0 | 2026-05-22 | 2026-05-29 |
Marquet Magda Director · Stock Option (Right to Buy) · 2026-05-22 | Grant | 12.5K | $0 | 2026-05-22 | 2026-05-29 |
BUCHAN JANE Director · Stock Option (Right to Buy) · 2026-05-22 | Grant | 12.5K | $0 | 2026-05-22 | 2026-05-29 |
CHANG NANCY T Director · Common Stock · 2026-05-22 | Other | — | — | 2026-05-22 | 2026-05-29 |
Hsu Jason Director · Common Stock · 2026-05-22 | Other | — | — | 2026-05-22 | 2026-05-29 |
Hsu Jason Director · Common Stock · 2026-05-22 | Grant | 6.25K | $0 | 2026-05-22 | 2026-05-29 |
Rachman Ilya M CEO and Chairman · Stock Option (Right to Buy) · 2026-05-22 | Grant | 500K | $0 | 2026-05-22 | 2026-05-29 |
SEC filings
EDGAR filings in IMMX · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.